Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Soy, soy phytoestrogens and cardiovascular disease.

Clarkson TB.

J Nutr. 2002 Mar;132(3):566S-569S. Review.

2.

Phytoestrogens and cardiovascular disease.

Cassidy A, Hooper L.

J Br Menopause Soc. 2006 Jun;12(2):49-56. Review.

PMID:
16776855
3.

Soy, isoflavones and atherosclerosis.

Clair RS, Anthony M.

Handb Exp Pharmacol. 2005;(170):301-23. Review.

PMID:
16596804
4.

Hormonal effects of soy in premenopausal women and men.

Kurzer MS.

J Nutr. 2002 Mar;132(3):570S-573S. Review.

5.

Soy protein isoflavones, lipids and arterial disease.

Vitolins MZ, Anthony M, Burke GL.

Curr Opin Lipidol. 2001 Aug;12(4):433-7. Review.

PMID:
11507329
6.

Do soy isoflavones lower cholesterol, inhibit atherosclerosis, and play a role in cancer prevention?

Arliss RM, Biermann CA.

Holist Nurs Pract. 2002 Oct;16(5):40-8. Review.

PMID:
12465217
7.

Dietary soy-derived isoflavone phytoestrogens. Could they have a role in coronary heart disease prevention?

Tikkanen MJ, Adlercreutz H.

Biochem Pharmacol. 2000 Jul 1;60(1):1-5. Review.

PMID:
10807939
8.

Phytoestrogens and coronary heart disease.

Clarkson TB, Anthony MS.

Baillieres Clin Endocrinol Metab. 1998 Dec;12(4):589-604. Review.

PMID:
10384815
9.

Soy isoflavones: a safety review.

Munro IC, Harwood M, Hlywka JJ, Stephen AM, Doull J, Flamm WG, Adlercreutz H.

Nutr Rev. 2003 Jan;61(1):1-33. Review.

PMID:
12638461
10.

The cardiovascular effects of soy products.

Hasler CM.

J Cardiovasc Nurs. 2002 Jul;16(4):50-63; quiz 75-6. Review.

PMID:
12597262
11.

Beneficial role of dietary phytoestrogens in obesity and diabetes.

Bhathena SJ, Velasquez MT.

Am J Clin Nutr. 2002 Dec;76(6):1191-201. Review.

12.

Effects of soy and other natural products on LDL:HDL ratio and other lipid parameters: a literature review.

Hermansen K, Dinesen B, Hoie LH, Morgenstern E, Gruenwald J.

Adv Ther. 2003 Jan-Feb;20(1):50-78. Review.

PMID:
12772818
13.

Phytoestrogen supplement use by women.

Kurzer MS.

J Nutr. 2003 Jun;133(6):1983S-1986S. Review.

14.

Phyto-oestrogens and cardiovascular disease risk.

van der Schouw YT, de Kleijn MJ, Peeters PH, Grobbee DE.

Nutr Metab Cardiovasc Dis. 2000 Jun;10(3):154-67. Review.

PMID:
11006924
15.

Soy protein and serum lipids.

Potter SM.

Curr Opin Lipidol. 1996 Aug;7(4):260-4. Review.

PMID:
8883502
16.

High-density lipoproteins: effects of alcohol, estrogen, and phytoestrogens.

Lamon-Fava S.

Nutr Rev. 2002 Jan;60(1):1-7. Review.

PMID:
11842998
17.

[Soy and phytoestrogens consumption and health policy hesitation or certitude].

Nitzan-Kaluski D, Stern F, Kachel J, Leventhal A.

Harefuah. 2002 Jan;141(1):61-6, 125. Review. Hebrew.

PMID:
11851111
18.

Protective effects of dietary phytoestrogens in chronic renal disease.

Ranich T, Bhathena SJ, Velasquez MT.

J Ren Nutr. 2001 Oct;11(4):183-93. Review.

PMID:
11679998
19.

Dietary protein type and cardiovascular disease risk factors.

Vega-López S, Lichtenstein AH.

Prev Cardiol. 2005 Winter;8(1):31-40. Review.

20.

Role of isoflavones in the hypocholesterolemic effect of soy.

Demonty I, Lamarche B, Jones PJ.

Nutr Rev. 2003 Jun;61(6 Pt 1):189-203. Review.

PMID:
12903829

Supplemental Content

Support Center